|
1
|
Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.
|
Cell Calcium
|
2006
|
1.12
|
|
2
|
Presenilin-2 dampens intracellular Ca2+ stores by increasing Ca2+ leakage and reducing Ca2+ uptake.
|
J Cell Mol Med
|
2009
|
1.01
|
|
3
|
Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility.
|
Mol Biol Cell
|
2010
|
0.96
|
|
4
|
Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis.
|
J Cell Mol Med
|
2011
|
0.95
|
|
5
|
Chromatin-modifying agents in anti-cancer therapy.
|
Biochimie
|
2012
|
0.86
|
|
6
|
Grp94 acts as a mediator of curcumin-induced antioxidant defence in myogenic cells.
|
J Cell Mol Med
|
2010
|
0.83
|
|
7
|
Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells.
|
J Med Chem
|
2014
|
0.83
|
|
8
|
Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system.
|
Mol Cancer Ther
|
2009
|
0.83
|
|
9
|
Recombinant differential anchorage probes that tower over the spatial dimension of intracellular signals for high content screening and analysis.
|
Anal Chem
|
2009
|
0.79
|
|
10
|
Redox regulation: natural compound as regulators of inflammation signaling.
|
Biochem Pharmacol
|
2012
|
0.78
|
|
11
|
Editorial: Novel Pharmaceutical Approaches by Natural Compound-Derived Epigenetic Regulators: Epigenetic Readers, Writers and Erasers as Therapeutic Targets.
|
Curr Top Med Chem
|
2016
|
0.76
|
|
12
|
Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments.
|
Curr Top Med Chem
|
2016
|
0.76
|